How the geopolitical situation is affecting medicines in Spain

The development of a new medicine is a long, complex and high-risk process. Every new treatment—from a therapy for diabetes to a drug for a rare disease—is the result of years of research, thousands of professionals involved and a very substantial investment that is funded, to a large extent, by the revenue generated from medicines […]
Spain is stepping up the pace in the long-term race for clinical trials

lavanguardia.com Before finally agreeing to her doctor’s proposal, Cecilia Rodríguez had undergone chemotherapy, radiotherapy and immunotherapy. The cancer she had been living with for six years had spread, and her oncologist told her about an experimental treatment being trialled by a Japanese pharmaceutical company in Barcelona. This marked the start of her first experience as […]
Fortrea is driving the digitalisation of clinical trials with an AI-powered platform

The new FIT solution aims to automate processes, improve decision-making and boost efficiency in clinical development Consalud.es Fortrea has announced the launch of Fortrea Intelligent Technology (FIT), a suite of AI-powered tools designed to transform clinical trial management by automating processes and improving operational efficiency. The North Carolina-based company unveiled the platform on 7 April […]
Nanotechnology is driving a new generation of more effective and personalised medicines

The use of nanoparticles is transforming pharmaceutical formulation, improving bioavailability and the development of targeted therapies. consalud.es The development of new medicines is one of the most complex and costly processes in the pharmaceutical industry. It can take more than ten years from the discovery of a molecule to its market launch, with clinical trials […]
Spain is preparing to move from clinical trials to the successful use of health data

The roll-out of the European Health Data Space marks a new chapter in innovation, research and evidence-based practice redaccionmedica.com The search for scientific evidence and the exploitation of health data have never been so deeply embedded in the functioning of a shared space such as the European one. Now, the roll-out of the European Health […]
200 new medicines and nearly €18 billion for the European economy: the potential of a more competitive biopharmaceutical sector over the next decade

A new report by CRA for the European Federation of Pharmaceutical Industries and Associations (EFPIA) explains what Europeans stand to gain if the region regains competitiveness against the US and China Spain is the only country in Europe that is gaining market share in clinical trials, but the continent has gone from hosting 22% of […]
The pharmaceutical industry and its environmental footprint: the urgent challenge of transforming its packaging

A study warns that less than 10% of plastic packaging is recycled Consalud.es Sustainability has moved beyond being merely a reputational issue to become a structural factor in competitiveness within the pharmaceutical industry. According to academic research on sustainability in pharmaceutical packaging carried out at EAN University, the current model is environmentally unsustainable and faces […]
Madrid is launching a groundbreaking clinical trial that paves the way for pioneering treatments for ALS
The drug aims to restore the function of the protein that causes motor neuron death, and the new molecule could slow the progression of amyotrophic lateral sclerosis Consalud.es This coming April, the Community of Madrid is launching a groundbreaking clinical trial at the Institute of Health Research at La Princesa Public Hospital, paving the way […]
Clinical trials as catalysts for change in clinical practice for healthcare professionals

Pharmaceutical innovation is about more than just developing new treatments. Researchers from the Ramón y Cajal and 12 de Octubre hospitals are examining the contribution of clinical trials to clinical practice. Clinical trials that lead to pharmaceutical innovations generate far more than just cutting-edge medicines for unmet medical needs. They also represent investment, job creation, […]
Nobel Prize for Medicine 2018 for cancer immunotherapy

Source: IntraMed The American James Allison and the Japanese Tasuku Honjo have won the Nobel Prize for Medicine 2018. The jury of the Karolinska Institute in Stockholm has awarded the prize to these two scientists for “their discovery of cancer therapy by inhibiting negative immune regulation ” The findings of both scientists have been essential […]